ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,37%
Bitcoin
61.229,76
0,71%
Brent Oil
82,585
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Silence Therapeutics Plc (SLN)

  7. Silence Therapeutics Plc (SLN) Notícias

SLN

Silence Therapeutics (SLN)

Silence Therapeutics Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:SLN
DataHoraFonteTítuloCódigoCompanhia
26/11/202109:59Alliance NewsAlliance NewsIN BRIEF: Silence Therapeutics to delist from AIM next weekLSE:SLNSilence Therapeutics Plc
26/11/202104:00UK RegulatorySilence Therapeutics PLC Update on AIM DelistingLSE:SLNSilence Therapeutics Plc
25/11/202114:30UK RegulatoryFTSE Russell Silence TherapeuticsLSE:SLNSilence Therapeutics Plc
16/11/202109:23Alliance NewsAlliance NewsTRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum noteLSE:SLNSilence Therapeutics Plc
16/11/202104:00UK RegulatorySilence Therapeutics PLC Third Quarter 2021 Financial ResultsLSE:SLNSilence Therapeutics Plc
11/11/202104:00UK RegulatorySilence Therapeutics PLC Silence to Present at Jefferies London ConferenceLSE:SLNSilence Therapeutics Plc
10/11/202104:00UK RegulatorySilence Therapeutics PLC Holding(s) in CompanyLSE:SLNSilence Therapeutics Plc
05/11/202115:40Alliance NewsAlliance NewsIN BRIEF: Frazier Life picks up 3% interest in Silence TherapeuticsLSE:SLNSilence Therapeutics Plc
05/11/202104:00UK RegulatorySilence Therapeutics PLC New Key ShareholderLSE:SLNSilence Therapeutics Plc
01/11/202114:33UK RegulatorySilence Therapeutics PLC Result of General MeetingLSE:SLNSilence Therapeutics Plc
01/11/202113:49UK RegulatorySilence Therapeutics PLC Total Voting RightsLSE:SLNSilence Therapeutics Plc
22/10/202116:26Alliance NewsAlliance NewsIN BRIEF: Silence Therapeutics reports solid progress across pipelinesLSE:SLNSilence Therapeutics Plc
21/10/202109:30UK RegulatorySilence Therapeutics PLC Silence Provides Pipeline Updates at 2021 R&D DayLSE:SLNSilence Therapeutics Plc
15/10/202111:40Alliance NewsAlliance NewsCORRECT: Silence Therapeutics to delist from AIM; teams with HansohLSE:SLNSilence Therapeutics Plc
15/10/202110:15Alliance NewsAlliance NewsIN BRIEF: Silence Therapeutics to delist from AIM; unites with HansohLSE:SLNSilence Therapeutics Plc
15/10/202103:05UK RegulatorySilence Therapeutics PLC Proposed Cancellation of Trading on AIMLSE:SLNSilence Therapeutics Plc
15/10/202103:00UK RegulatorySilence Therapeutics PLC Silence and Hansoh Pharma Announce CollaborationLSE:SLNSilence Therapeutics Plc
08/10/202103:00UK RegulatorySilence Therapeutics PLC Block Listing ReturnLSE:SLNSilence Therapeutics Plc
07/10/202103:00UK RegulatorySilence Therapeutics PLC Silence Therapeutics to host R&D dayLSE:SLNSilence Therapeutics Plc
28/09/202103:00UK RegulatorySilence Therapeutics PLC Chardan Genetic Medicines Conference ParticipationLSE:SLNSilence Therapeutics Plc
01/09/202103:00UK RegulatorySilence Therapeutics PLC Silence Appoints Senior VP of BD, AM and NPD.LSE:SLNSilence Therapeutics Plc
25/08/202103:00UK RegulatorySilence Therapeutics PLC Silence to Participate in Investor ConferencesLSE:SLNSilence Therapeutics Plc
12/08/202109:56Alliance NewsAlliance NewsIN BRIEF: Silence Therapeutics revenue up, new targets with AstraZenecaLSE:SLNSilence Therapeutics Plc
12/08/202103:00UK RegulatorySilence Therapeutics PLC Silence Therapeutics Report Half-Year 2021 ResultsLSE:SLNSilence Therapeutics Plc
15/07/202103:00UK RegulatorySilence Therapeutics PLC Notice of half year resultsLSE:SLNSilence Therapeutics Plc
15/06/202113:54UK RegulatorySilence Therapeutics PLC Results of Annual General MeetingLSE:SLNSilence Therapeutics Plc
07/06/202103:00UK RegulatorySilence Therapeutics PLC Silence to present SL124 data at EHALSE:SLNSilence Therapeutics Plc
25/05/202115:40Alliance NewsAlliance NewsTRADING UPDATES: Bank of Cyprus outlook hinges on tourism industryLSE:SLNSilence Therapeutics Plc
25/05/202103:00UK RegulatorySilence Therapeutics PLC $40m Payment from AstraZeneca for CollaborationLSE:SLNSilence Therapeutics Plc
19/05/202115:33Alliance NewsAlliance NewsTRADING UPDATES: Young's mulls asset sale; Ceres gets China investmentLSE:SLNSilence Therapeutics Plc
 Apresentando as notícias mais relevantes sobre:LSE:SLN

Seu Histórico Recente

UNSW3
TUBGIRLETH
Tub Girl
BIT
P1VSF8
NLBNPIT1VSF8 20991231 34...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados